FROEDTERT SOUTH — History
CCN 520021 | 3-year financial timeline | COVID resilience: 48/100
🛡️ Public data only — no PHI permitted on this instance.
$372M
Latest Revenue (FY2022)
+3.6%
Revenue CAGR (3yr)
3.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $347M | $372M | $372M | +0.1% | +3.6% |
| Operating Expenses | $334M | $354M | $358M | +0.9% | +3.5% |
| Operating Margin | 3.8% | 4.7% | 3.9% | -15.2% | +2.5% |
| Net Income | $13M | $17M | $15M | -15.1% | +6.2% |
| Licensed Beds | 194 | 228 | 173 | -24.1% | -5.6% |
| Total Patient Days | 30,940 | 32,864 | 27,200 | -17.2% | -6.2% |
| Medicare Day % | 32% | 31% | 28% | -8.0% | -5.9% |
| Medicaid Day % | 8% | 7% | 7% | -4.5% | -7.4% |
COVID Impact & Recovery
Resilience Score: 48/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +7.4% ($347M → $372M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.6%
This Hospital
+7.6%
State Avg
Latest Margin
3.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $385M | 4.0% |
| FY2024 (proj) | $398M | 4.1% |
| FY2025 (proj) | $411M | 4.2% |